Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B
Clinical trial NCT07588009 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07588009
- Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2028-01-11
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.